Tpl2 enzyme may be target for treating autoimmune diseases

May 22, 2015 by Molly Berg, University of Georgia
Nicole Acuff, left, studies whether Tpl2, a proinflammatory enzyme known as tumor locus progression 2, contributed to colitis caused by self-reactive T cells. Her research is guided by Wendy Watford, right, an assistant professor in the department of infectious diseases. Credit: Robert Newcomb/UGA

New research at the University of Georgia has found that the presence of Tpl2—an enzyme that regulates inflammation—controls the activation of T cells during colitis, an autoimmune disease that occurs when the inner lining of the colon is inflamed.

Autoimmune diseases, like colitis, are estimated to affect 5 to 8 percent of the population. Side effects of colitis can include abdominal pain, and diarrhea. Since there is no cure for colitis, most patients use medications to treat their symptoms. Figuring out the cause of colitis and how to cure it has challenged researchers for years.

Multiple cell types contribute to colitis development, including T cells. In this study, Nicole Acuff, a fourth-year Ph.D. student in the UGA College of Veterinary Medicine, led the research designed to see whether Tpl2, a proinflammatory enzyme known as tumor locus progression 2, contributed to colitis caused by self-reactive T cells.

Under the guidance of Wendy Watford, an assistant professor in the department of infectious diseases, Acuff examined the role of Tpl2 in the activation of T cells during development of the disease. The study was published recently in PLOS One.

"We specifically wanted to know how Tpl2 influences Th1 and Th17 cell development," Acuff said.

"Although these two types of T cells are important for fighting off different types of infections, their activation can go awry and lead to diverse autoimmune diseases, including colitis, rheumatoid arthritis and multiple sclerosis," Watford said.

Acuff found that when Tpl2-deficient T cells were administered to T cell-deficient mice, they were equally likely to become Th17 cells but significantly less likely to become Th1 cells. These findings suggest that Tpl2 regulates the type of inflammatory response that develops and could be targeted to treat specific types of autoimmunity. In addition, Tpl2 deficiency promotes production of anti-inflammatory proteins that antagonize Th1 and Th17 responses.

Since the research studied Tpl2's effect on mice, Acuff said that future tests are needed to better understand Tpl2 and how it could treat in humans. Follow-up studies should also examine the effects of Tpl2 on other caused by activated T .

Explore further: Researchers discover new method to reduce disease-causing inflammation

More information: "Tumor Progression Locus 2 Differentially Regulates IFNγ and IL-17 Production by Effector CD4+ T Cells in a T Cell Transfer Model of Colitis." PLoS ONE 10(3): e0119885. DOI: 10.1371/journal.pone.0119885

Related Stories

Researchers discover new method to reduce disease-causing inflammation

June 16, 2014
Researchers at the University of Georgia report in the Journal of Biological Chemistry that an enzyme known as Tumor Progression Locus 2, or Tpl2, plays a key role in directing and regulating several important components ...

Inflammatory immune cells can flip the genetic script

April 30, 2015
A type of immune cell that promotes inflammation during the immune response, TH17, can convert into another type of cell that reduces inflammation, Yale researchers have found. The finding, published April 29 in Nature, points ...

Multiple sclerosis: Scientists ID cause of movement, balance problems

May 19, 2015
New research into the causes of the excessive inflammation that drives multiple sclerosis has identified a faulty "brake" within immune cells, a brake that should be controlling the inflammation. This points to a potential ...

Protein identified that serves as a 'brake' on inflammation

April 21, 2015
Researchers have identified a protein that offers a new focus for developing targeted therapies to tame the severe inflammation associated with multiple sclerosis (MS), colitis and other autoimmune disorders. St. Jude Children's ...

Scientists discover potential new treatment for multiple sclerosis

April 27, 2015
Scientists from the Gladstone Institutes have discovered a way to prevent the development of multiple sclerosis (MS) in mice. Using a drug that blocks the production of a certain type of immune cell linked to inflammation ...

Recommended for you

A synthetic approach to helping the immune system thwart infections

February 22, 2018
Yale researchers have developed a set of synthetic molecules that may help boost the strength of a key, virus-fighting protein.

Scientists find molecular link between Vitamin A derivative and mouse intestinal health

February 22, 2018
New research shows that all-trans-retinoic acid (atRA), the active form of vitamin A, regulates immune system responses in the mouse intestine by controlling expression of the protein HIC1 in cells known as innate lymphoid ...

Animal study shows how to retrain the immune system to ease food allergies

February 21, 2018
Treating food allergies might be a simple matter of teaching the immune system a new trick, researchers at Duke Health have found.

'Icebreaker' protein opens genome for T cell development, researchers find

February 20, 2018
Almost all cells in the human body have identical DNA sequences, yet there are 200-plus cell types with different sizes, shapes, and chemical compositions. Determining what parts of the genome are read to make protein and ...

Preventive treatment for peanut allergies succeeds in study

February 20, 2018
The first treatment to help prevent serious allergic reactions to peanuts may be on the way. A company said Tuesday that its daily capsules of peanut powder helped children build tolerance in a major study.

Infection site affects how a virus spreads through the body

February 20, 2018
A person is more likely to get infected by HIV through anal intercourse than vaginal, but no one knows quite why. A new study by scientists at the Gladstone Institutes shows that infection sites could affect the immune system's ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.